Network origin in Stanislav Karpenko first degree
Entity | Entity type | Industry | |
---|---|---|---|
Vision Technologies Ltd.
Vision Technologies Ltd. Packaged SoftwareTechnology Services Vision Technologies Ltd. develops software for wearable devices that has the potential to transform the lives of blind and visually impaired. The company was founded by Stanislav Karpenko in June 2014 and is headquartered in London, the United Kingdom.
6
| Holding Company | Packaged Software | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stanislav Karpenko via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Atheer, Inc.
Atheer, Inc. Packaged SoftwareTechnology Services Atheer, Inc. provides an augmented reality management platform for industrial enterprises. It offers enterprise grade solutions for contextual work guidance, remote collaboration, and natural interaction across glasses and mobile devices. The company was founded by Soulaiman Itani on February 14, 2012 and is headquartered in Santa Clara, CA. | Packaged Software | Founder | |
NupulseCV, Inc.
NupulseCV, Inc. Medical SpecialtiesHealth Technology NupulseCV, Inc. operates as a medical device company that develops technology to treat patients with heart failure. Its device which requires a minimally invasive surgery provides patients an alternative to medical therapy. The firm maintains strategic and financial partnership with heart failure companies around the world. The company was founded in 2010 and is headquartered in Raleigh, NC. | Medical Specialties | Director/Board Member | |
Felicitex Therapeutics, Inc.
Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Constant Therapeutics LLC | Director/Board Member | ||
iPulse Ltd.
iPulse Ltd. Medical SpecialtiesHealth Technology iPulse Ltd. engages in the manufacture of medical and dental instruments. The company was founded on November 23, 2012 and is headquartered in Swansea, the United Kingdom. | Medical Specialties | Director/Board Member |
Statistics
International
United States | 6 |
United Kingdom | 2 |
Sectoral
Health Technology | 3 |
Distribution Services | 2 |
Technology Services | 2 |
Commercial Services | 2 |
Operational
Director/Board Member | 8 |
Founder | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Chief Executive Officer | 2 |
Independent Dir/Board Member | 1 |
Most connected contacts
- Stock Market
- Insiders
- Stanislav Karpenko
- Company connections